Latest Fibrosis Treatment News

Page 1 of 1

Vectus Validates Fibrosis Drug Safety, Eyes Licensing Deals in China and Beyond

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.

Ada Torres

31 July 2025

Top